Associations  ||| S:0 E:13 ||| NNS
of  ||| S:13 E:16 ||| IN
Walking  ||| S:16 E:24 ||| NNP
Speed ||| S:24 E:29 ||| NNP
,  ||| S:29 E:31 ||| ,
Grip  ||| S:31 E:36 ||| NNP
Strength ||| S:36 E:44 ||| NNP
,  ||| S:44 E:46 ||| ,
and  ||| S:46 E:50 ||| CC
Standing  ||| S:50 E:59 ||| NNP
Balance  ||| S:59 E:67 ||| NNP
With  ||| S:67 E:72 ||| IN
Total  ||| S:72 E:78 ||| JJ
and  ||| S:78 E:82 ||| CC
Cause-Specific  ||| S:82 E:97 ||| NNP
Mortality  ||| S:97 E:107 ||| NNP
in  ||| S:107 E:110 ||| IN
a  ||| S:110 E:112 ||| DT
General  ||| S:112 E:120 ||| NNP
Population  ||| S:120 E:131 ||| NNP
of  ||| S:131 E:134 ||| IN
Japanese  ||| S:134 E:143 ||| JJ
Elders  ||| S:143 E:150 ||| NNP
Walking  ||| S:150 E:158 ||| NNP
speed ||| S:158 E:163 ||| NN
,  ||| S:163 E:165 ||| ,
grip  ||| S:165 E:170 ||| NN
strength ||| S:170 E:178 ||| NN
,  ||| S:178 E:180 ||| ,
and  ||| S:180 E:184 ||| CC
standing  ||| S:184 E:193 ||| VBG
balance  ||| S:193 E:201 ||| NN
are  ||| S:201 E:205 ||| VBP
key  ||| S:205 E:209 ||| JJ
components  ||| S:209 E:220 ||| NNS
of  ||| S:220 E:223 ||| IN
physical  ||| S:223 E:232 ||| JJ
performance  ||| S:232 E:244 ||| NN
in  ||| S:244 E:247 ||| IN
older  ||| S:247 E:253 ||| JJR
people ||| S:253 E:259 ||| NNS
.  ||| S:259 E:261 ||| .
The  ||| S:261 E:265 ||| DT
present  ||| S:265 E:273 ||| JJ
study  ||| S:273 E:279 ||| NN
aimed  ||| S:279 E:285 ||| VBN
to  ||| S:285 E:288 ||| TO
evaluate  ||| S:288 E:297 ||| VB
( ||| S:297 E:298 ||| -LRB-
1 ||| S:298 E:299 ||| LS
)  ||| S:299 E:301 ||| -RRB-
associations  ||| S:301 E:314 ||| NNS
of  ||| S:314 E:317 ||| IN
these  ||| S:317 E:323 ||| DT
physical  ||| S:323 E:332 ||| JJ
performance  ||| S:332 E:344 ||| NN
measures  ||| S:344 E:353 ||| NNS
with  ||| S:353 E:358 ||| IN
cause-specific  ||| S:358 E:373 ||| JJ
mortality ||| S:373 E:382 ||| NN
,  ||| S:382 E:384 ||| ,
( ||| S:384 E:385 ||| -LRB-
2 ||| S:385 E:386 ||| LS
)  ||| S:386 E:388 ||| -RRB-
independent  ||| S:388 E:400 ||| JJ
associations  ||| S:400 E:413 ||| NNS
of  ||| S:413 E:416 ||| IN
individual  ||| S:416 E:427 ||| JJ
physical  ||| S:427 E:436 ||| JJ
performance  ||| S:436 E:448 ||| NN
measures  ||| S:448 E:457 ||| NNS
with  ||| S:457 E:462 ||| IN
mortality ||| S:462 E:471 ||| NN
,  ||| S:471 E:473 ||| ,
and  ||| S:473 E:477 ||| CC
( ||| S:477 E:478 ||| -LRB-
3 ||| S:478 E:479 ||| LS
)  ||| S:479 E:481 ||| -RRB-
the  ||| S:481 E:485 ||| DT
added  ||| S:485 E:491 ||| JJ
value  ||| S:491 E:497 ||| NN
of  ||| S:497 E:500 ||| IN
combined  ||| S:500 E:509 ||| JJ
use  ||| S:509 E:513 ||| NN
of  ||| S:513 E:516 ||| IN
the  ||| S:516 E:520 ||| DT
3  ||| S:520 E:522 ||| CD
physical  ||| S:522 E:531 ||| JJ
performance  ||| S:531 E:543 ||| NN
measures  ||| S:543 E:552 ||| NNS
in  ||| S:552 E:555 ||| IN
predicting  ||| S:555 E:566 ||| VBG
all-cause  ||| S:566 E:576 ||| JJ
and  ||| S:576 E:580 ||| CC
cause-specific  ||| S:580 E:595 ||| JJ
mortality ||| S:595 E:604 ||| NN
.  ||| S:604 E:606 ||| .
Prospective  ||| S:606 E:618 ||| JJ
cohort  ||| S:618 E:625 ||| JJ
study  ||| S:625 E:631 ||| NN
with  ||| S:631 E:636 ||| IN
a  ||| S:636 E:638 ||| DT
follow-up  ||| S:638 E:648 ||| JJ
of  ||| S:648 E:651 ||| IN
10.5 years ||| S:651 E:661 ||| CD
.  ||| S:661 E:663 ||| .
Tokyo  ||| S:663 E:669 ||| NNP
Metropolitan  ||| S:669 E:682 ||| NNP
Institute  ||| S:682 E:692 ||| NNP
of  ||| S:692 E:695 ||| IN
Gerontology  ||| S:695 E:707 ||| NNP
Longitudinal  ||| S:707 E:720 ||| NNP
Interdisciplinary  ||| S:720 E:738 ||| NNP
Study  ||| S:738 E:744 ||| NNP
on  ||| S:744 E:747 ||| IN
Aging  ||| S:747 E:753 ||| NNP
( ||| S:753 E:754 ||| -LRB-
TMIG-LISA ||| S:754 E:763 ||| NNP
) ||| S:763 E:764 ||| -RRB-
,  ||| S:764 E:766 ||| ,
Japan ||| S:766 E:771 ||| NNP
.  ||| S:771 E:773 ||| .
A  ||| S:773 E:775 ||| DT
total  ||| S:775 E:781 ||| NN
of  ||| S:781 E:784 ||| IN
1085  ||| S:784 E:789 ||| CD
initially  ||| S:789 E:799 ||| RB
nondisabled  ||| S:799 E:811 ||| VB
older  ||| S:811 E:817 ||| JJR
Japanese  ||| S:817 E:826 ||| NNS
aged  ||| S:826 E:831 ||| VBN
65  ||| S:831 E:834 ||| CD
to  ||| S:834 E:837 ||| TO
89 years ||| S:837 E:845 ||| CD
.  ||| S:845 E:847 ||| .
Usual  ||| S:847 E:853 ||| JJ
walking  ||| S:853 E:861 ||| NN
speed ||| S:861 E:866 ||| NN
,  ||| S:866 E:868 ||| ,
grip  ||| S:868 E:873 ||| NN
strength ||| S:873 E:881 ||| NN
,  ||| S:881 E:883 ||| ,
and  ||| S:883 E:887 ||| CC
standing  ||| S:887 E:896 ||| VBG
balance  ||| S:896 E:904 ||| NN
were  ||| S:904 E:909 ||| VBD
measured  ||| S:909 E:918 ||| VBN
at  ||| S:918 E:921 ||| IN
baseline  ||| S:921 E:930 ||| JJ
survey ||| S:930 E:936 ||| NN
.  ||| S:936 E:938 ||| .
During  ||| S:938 E:945 ||| IN
follow-up ||| S:945 E:954 ||| NNP
,  ||| S:954 E:956 ||| ,
324  ||| S:956 E:960 ||| CD
deaths  ||| S:960 E:967 ||| NNS
occurred  ||| S:967 E:976 ||| VBD
( ||| S:976 E:977 ||| -LRB-
122  ||| S:977 E:981 ||| CD
of  ||| S:981 E:984 ||| IN
cardiovascular  ||| S:984 E:999 ||| JJ
disease ||| S:999 E:1006 ||| NN
,  ||| S:1006 E:1008 ||| ,
75  ||| S:1008 E:1011 ||| CD
of  ||| S:1011 E:1014 ||| IN
cancer ||| S:1014 E:1020 ||| NN
,  ||| S:1020 E:1022 ||| ,
115  ||| S:1022 E:1026 ||| CD
of  ||| S:1026 E:1029 ||| IN
other  ||| S:1029 E:1035 ||| JJ
causes ||| S:1035 E:1041 ||| NNS
,  ||| S:1041 E:1043 ||| ,
and  ||| S:1043 E:1047 ||| CC
12  ||| S:1047 E:1050 ||| CD
of  ||| S:1050 E:1053 ||| IN
unknown  ||| S:1053 E:1061 ||| JJ
causes ||| S:1061 E:1067 ||| NNS
) ||| S:1067 E:1068 ||| -RRB-
.  ||| S:1068 E:1070 ||| .
All  ||| S:1070 E:1074 ||| DT
3  ||| S:1074 E:1076 ||| CD
physical  ||| S:1076 E:1085 ||| JJ
performance  ||| S:1085 E:1097 ||| NN
measures  ||| S:1097 E:1106 ||| NNS
were  ||| S:1106 E:1111 ||| VBD
significantly  ||| S:1111 E:1125 ||| RB
associated  ||| S:1125 E:1136 ||| VBN
with  ||| S:1136 E:1141 ||| IN
all-cause ||| S:1141 E:1150 ||| NNP
,  ||| S:1150 E:1152 ||| ,
cardiovascular ||| S:1152 E:1166 ||| JJ
,  ||| S:1166 E:1168 ||| ,
and  ||| S:1168 E:1172 ||| CC
other-cause  ||| S:1172 E:1184 ||| JJ
mortality ||| S:1184 E:1193 ||| NN
,  ||| S:1193 E:1195 ||| ,
but  ||| S:1195 E:1199 ||| CC
not  ||| S:1199 E:1203 ||| RB
with  ||| S:1203 E:1208 ||| IN
cancer  ||| S:1208 E:1215 ||| NN
mortality ||| S:1215 E:1224 ||| NN
,  ||| S:1224 E:1226 ||| ,
independent  ||| S:1226 E:1238 ||| JJ
of  ||| S:1238 E:1241 ||| IN
potential  ||| S:1241 E:1251 ||| JJ
confounders ||| S:1251 E:1262 ||| NN
.  ||| S:1262 E:1264 ||| .
When  ||| S:1264 E:1269 ||| WRB
all  ||| S:1269 E:1273 ||| DT
3  ||| S:1273 E:1275 ||| CD
physical  ||| S:1275 E:1284 ||| JJ
performance  ||| S:1284 E:1296 ||| NN
measures  ||| S:1296 E:1305 ||| NNS
were  ||| S:1305 E:1310 ||| VBD
simultaneously  ||| S:1310 E:1325 ||| RB
entered  ||| S:1325 E:1333 ||| VBN
into  ||| S:1333 E:1338 ||| IN
the  ||| S:1338 E:1342 ||| DT
model ||| S:1342 E:1347 ||| NN
,  ||| S:1347 E:1349 ||| ,
each  ||| S:1349 E:1354 ||| DT
was  ||| S:1354 E:1358 ||| VBD
significantly  ||| S:1358 E:1372 ||| RB
independently  ||| S:1372 E:1386 ||| RB
associated  ||| S:1386 E:1397 ||| VBN
with  ||| S:1397 E:1402 ||| IN
all-cause  ||| S:1402 E:1412 ||| JJ
and  ||| S:1412 E:1416 ||| CC
cardiovascular  ||| S:1416 E:1431 ||| JJ
mortality ||| S:1431 E:1440 ||| NN
.  ||| S:1440 E:1442 ||| .
The  ||| S:1442 E:1446 ||| DT
C  ||| S:1446 E:1448 ||| NNP
statistics  ||| S:1448 E:1459 ||| NNS
for  ||| S:1459 E:1463 ||| IN
all-cause  ||| S:1463 E:1473 ||| JJ
and  ||| S:1473 E:1477 ||| CC
cardiovascular  ||| S:1477 E:1492 ||| JJ
mortality  ||| S:1492 E:1502 ||| NN
were  ||| S:1502 E:1507 ||| VBD
significantly  ||| S:1507 E:1521 ||| RB
increased  ||| S:1521 E:1531 ||| VBN
by  ||| S:1531 E:1534 ||| IN
adding  ||| S:1534 E:1541 ||| VBG
grip  ||| S:1541 E:1546 ||| NN
strength  ||| S:1546 E:1555 ||| NN
and  ||| S:1555 E:1559 ||| CC
standing  ||| S:1559 E:1568 ||| VBG
balance  ||| S:1568 E:1576 ||| NN
to  ||| S:1576 E:1579 ||| TO
walking  ||| S:1579 E:1587 ||| VBG
speed  ||| S:1587 E:1593 ||| NN
( ||| S:1593 E:1594 ||| -LRB-
P   ||| S:1594 E:1596 ||| NNP
< ||| S:1596 E:1597 ||| SYM
 .01 ||| S:1597 E:1601 ||| NNP
) ||| S:1601 E:1602 ||| -RRB-
,  ||| S:1602 E:1604 ||| ,
and  ||| S:1604 E:1608 ||| CC
the  ||| S:1608 E:1612 ||| DT
net  ||| S:1612 E:1616 ||| JJ
reclassification  ||| S:1616 E:1633 ||| JJ
improvement  ||| S:1633 E:1645 ||| NN
for  ||| S:1645 E:1649 ||| IN
them  ||| S:1649 E:1654 ||| PRP
was  ||| S:1654 E:1658 ||| VBD
estimated  ||| S:1658 E:1668 ||| VBN
at  ||| S:1668 E:1671 ||| IN
18.7 ||| S:1671 E:1675 ||| CD
%  ||| S:1675 E:1677 ||| NN
and  ||| S:1677 E:1681 ||| CC
7.5 ||| S:1681 E:1684 ||| CD
% ||| S:1684 E:1685 ||| NN
,  ||| S:1685 E:1687 ||| ,
respectively ||| S:1687 E:1699 ||| RB
.  ||| S:1699 E:1701 ||| .
Slow  ||| S:1701 E:1706 ||| JJ
walking  ||| S:1706 E:1714 ||| NN
speed ||| S:1714 E:1719 ||| NN
,  ||| S:1719 E:1721 ||| ,
weak  ||| S:1721 E:1726 ||| JJ
grip  ||| S:1726 E:1731 ||| NN
strength ||| S:1731 E:1739 ||| NN
,  ||| S:1739 E:1741 ||| ,
and  ||| S:1741 E:1745 ||| CC
poor  ||| S:1745 E:1750 ||| JJ
standing  ||| S:1750 E:1759 ||| NN
balance  ||| S:1759 E:1767 ||| NN
predicted  ||| S:1767 E:1777 ||| VBD
all-cause ||| S:1777 E:1786 ||| JJ
,  ||| S:1786 E:1788 ||| ,
cardiovascular ||| S:1788 E:1802 ||| JJ
,  ||| S:1802 E:1804 ||| ,
and  ||| S:1804 E:1808 ||| CC
other-cause  ||| S:1808 E:1820 ||| JJ
mortality ||| S:1820 E:1829 ||| NN
,  ||| S:1829 E:1831 ||| ,
but  ||| S:1831 E:1835 ||| CC
not  ||| S:1835 E:1839 ||| RB
cancer  ||| S:1839 E:1846 ||| NN
mortality ||| S:1846 E:1855 ||| NN
,  ||| S:1855 E:1857 ||| ,
independent  ||| S:1857 E:1869 ||| JJ
of  ||| S:1869 E:1872 ||| IN
covariates ||| S:1872 E:1882 ||| NN
.  ||| S:1882 E:1884 ||| .
Moreover ||| S:1884 E:1892 ||| RB
,  ||| S:1892 E:1894 ||| ,
these  ||| S:1894 E:1900 ||| DT
3  ||| S:1900 E:1902 ||| CD
components  ||| S:1902 E:1913 ||| NNS
of  ||| S:1913 E:1916 ||| IN
physical  ||| S:1916 E:1925 ||| JJ
performance  ||| S:1925 E:1937 ||| NN
were  ||| S:1937 E:1942 ||| VBD
independently  ||| S:1942 E:1956 ||| RB
associated  ||| S:1956 E:1967 ||| VBN
with  ||| S:1967 E:1972 ||| IN
all-cause  ||| S:1972 E:1982 ||| JJ
and  ||| S:1982 E:1986 ||| CC
cardiovascular  ||| S:1986 E:2001 ||| JJ
mortality  ||| S:2001 E:2011 ||| NN
and  ||| S:2011 E:2015 ||| CC
their  ||| S:2015 E:2021 ||| PRP$
combined  ||| S:2021 E:2030 ||| JJ
use  ||| S:2030 E:2034 ||| NN
increased  ||| S:2034 E:2044 ||| VBD
prognostic  ||| S:2044 E:2055 ||| JJ
power ||| S:2055 E:2060 ||| NN
.  ||| S:2060 E:2062 ||| .
